314130 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Genome & Co. engages in research and development of dietary supplements, cosmeceuticals, and new drugs utilizing human microbiome. The company was founded by Ji-Soo Bae and Han-Su Park on September 24, 2015 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
314130 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company